The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Second-line therapy with Nal-IRI/5-FU/FA after failure of gemcitabine/nab-paclitaxel in advanced pancreatic cancer (PC): Predictive role of 1st-line therapy (PREDICT) and impact of quality of life (QoL).
 
Meinolf Karthaus
Travel, Accommodations, Expenses - SERVIER
 
Jerome Schwingel
No Relationships to Disclose
 
Hans Bauer
No Relationships to Disclose
 
Nikolaus Ansorge
No Relationships to Disclose
 
Gleb Barmashenko
No Relationships to Disclose
 
Christof Burkart
Consulting or Advisory Role - MSD
 
Thomas Ettrich
Consulting or Advisory Role - Abbvie; AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo Europe GmbH; Ipsen; Lilly; Merck Serono; MSD; Pierre Fabre; Roche; Sanofi; SERVIER; Takeda
Research Funding - Baxalta/Shire; Lilly (Inst)
Travel, Accommodations, Expenses - Ipsen; Lilly
 
Anke Gerhardt
No Relationships to Disclose
 
Sabine Hoefling
No Relationships to Disclose
 
Lutz Jacobasch
No Relationships to Disclose
 
Michael Koenigsmann
No Relationships to Disclose
 
Sebastian Räth
No Relationships to Disclose
 
Markos Schulte
No Relationships to Disclose
 
Nadine Schulte
No Relationships to Disclose
 
Andreas Schwarzer
No Relationships to Disclose
 
Gabriele Siegler
Honoraria - AstraZeneca; Aurikamed; BDI; Deutsche Röntgengesellschaft; Ipsen; Janssen; MCI Deutschland; Meet the Experts Academy; SERVIER
Consulting or Advisory Role - Amgen; Merck; MSD Oncology; Novartis; Roche; SERVIER
Travel, Accommodations, Expenses - Amgen; MCI Deutschland; Merck; Pierre Fabre; SERVIER
 
Dirk Waldschmidt
No Relationships to Disclose
 
Manfred Lutz
Consulting or Advisory Role - Amgen